ArticleFrontiers in pharmacology2025

Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer.

Junjie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.